An increasing number of studies have shown that plasma Fib has utility as a strong predictor of malignancy, and high levels of plasma Fib are significantly correlated with unfavorable outcomes in several cancers, including ovarian and pancreatic cancer [21–23]. The gene discussed is FBL; the disease is cancer.